Whitepaper: From bench to billions in cell and gene therapy


Download our new whitepaper ‘From bench to billions: A guide to facilitating scale-up of adherent cultures for cell and gene therapies’, brought you by Corning.

Given the potential of emerging advanced therapies, market demand is likely to continue to grow. Generating the required quantity of cells efficiently becomes even more challenging when the cells of interest are attachment-dependent, such as induced pluripotent stem cells (iPSCs). The choice of cell culture platform will have significant operational and commercial impacts.

Download the whitepaper to explore:

  • What researchers should consider when creating a risk-mitigating adherent culture process for cell and gene therapy scale-up
  • Key factors that should drive your long term scale-up plan
  • The operational impacts of platform choice

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free